Transcend · Navigate.pptx
V0.1
1
1
2
1
3
4
1
5
1
6
1
7
8
9
10
1
11
12
1
13
1
14
1
15
1
Review anomalies：10
This comment is Generated by AI
Audience Restriction / Material Type Mismatch
P1：
The claim is inconsistent with the material type. Please revise accordingly.
Extreme Wording Alert (Superlative)
P2：
Absolute/Superlative language detected. Please remove or rephrase for a more balanced tone.
Competitor Disparagement / Unfair Comparison
P4：
Disparagement of competitors is prohibited under competition regulations. Please revise to ensure a fair and objective comparison
Unsupported Absolute Claim
P5：
This is an absolute claim ('First Approved'). Please provide supporting references or official regulatory documentation to verify this statement.
Typographical Error
P6：
Typos.
Off-label Use Risk
P10：
This is an offlabel study of Drug A, please double check whether to remove or add a disclaimer based on LOC's regulations.
Incorrect Product-related Visual
P12：
Incorrect product icon/visual. Please revise.
National Symbol / Compliance Visual Issue
P13：
Inaccurate national symbols. Please update to the official version.
Extreme Wording Alert (Superlative)
P14：
Absolute/Superlative language detected. Please remove or rephrase for a more balanced tone.
Abbreviated Prescribing Information Reminder
P15：
Abbreviated Prescribing Information (aPI) for Drug A is required.
